Amedisys (AMED) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amedisys Reports Fourth Quarter and Year End 2021 Financial Results; Issues 2022 Guidance
February 23, 2022 4:05 PM ESTBATON ROUGE, La., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2021.
Three-Month Periods Ended December 31, 2021 and 2020
Net service revenue increased $8.6Â million to $559.3Â million compared to $550.7Â million in 2020.Net income attributable to Amedisys, Inc. of $34.0Â million compared to $45.2Â million in 2020.Net income attributable to Amedisys, Inc. per diluted share of $1.04 compared to $1.36 in 2020.Adjusted Quarterly Results*
Adjusted EBITDA of $64.8Â million compared to $78.1Â million in 2020.Adjusted net service revenue of $559.3Â million compared to $550.7Â million in... More


